COVID-19 in discharged patients with diabetes and chronic kidney disease: one-year follow-up and evaluation.

ABSTRACT:

Purpose

To evaluate the all-cause mortality rate and renal outcomes in patients with diabetes and chronic kidney disease (CKD) following hospital discharge for COVID-19.

Methods

This single-center prospective observational study included 187 discharged COVID-19 patients with diabetes and CKD, admitted between December 2022 and January 2023 at West China Hospital, Sichuan University. Cox regression analysis was used to assess mortality risk, and logistic regression was applied to identify risk factors for rapid CKD progression after discharge.

Results

During the one-year follow-up, the all-cause mortality rate was 26.7%, with a COVID-19-related acute kidney injury (AKI) incidence of 35.3%, and 35.8% of patients experienced rapid CKD progression after discharge. Cox pro

SUBMITTER: Ran E 

PROVIDER: S-EPMC11832373 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature